title: Pharmacokinetic bioequivalence crossover study of branded generic and innovator formulations of the cholesterol lowering agent ezetimibe.
authors.affiliation: GlaxoSmithKline, Uxbridge, Middlesex, UK.
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Palmer
authors.affiliation: Clinigene International Limited, Bangalore, India.
authors.forename: Anil
authors.initials: A
authors.lastname: Kunhihitlu
authors.affiliation: Laboratorios Phoenix S.A.I.C.F, Malvinas Argentinas, Provincia de Buenos Aires, Argentina.
authors.forename: Andrea
authors.initials: A
authors.lastname: Costantini
authors.affiliation: Laboratorios Phoenix S.A.I.C.F, Malvinas Argentinas, Provincia de Buenos Aires, Argentina.
authors.forename: Florencia
authors.initials: F
authors.lastname: Esquivel
authors.affiliation: GlaxoSmithKline, Research Triangle Park, NC, USA.
authors.forename: John
authors.initials: J
authors.lastname: Roush
authors.affiliation: GlaxoSmithKline, Harlow, UK.
authors.forename: Karina
authors.initials: K
authors.lastname: Edwards
authors.affiliation: Biopharma Consulting Ltd, Colwyn Bay, UK.
authors.forename: Thomas W K
authors.initials: TW
authors.lastname: Hill
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D018592:Cross-Over Studies; D004339:Drug Compounding; D016568:Drugs, Generic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000069438:Ezetimibe / Q000008:administration & dosage / Q000493:pharmacokinetics*; D064368:Healthy Volunteers; D006801:Humans; D008297:Male; D013810:Therapeutic Equivalency; D055815:Young Adult
chemical_list: D000924:Anticholesteremic Agents; D016568:Drugs, Generic; D000069438:Ezetimibe
keywords: bioequivalence; branded generic; ezetimibe; innovator